Add BrightSurf on Google Email

Eradivir’s EV25 therapeutic proven to reduce advanced-stage influenza viral loads faster, more thoroughly in preclinical studies than current therapies

EV25, a bispecific small molecule developed by Eradivir, acts faster than the current standard of care, eliminating detectable virus within 24 hours. It also recruits naturally occurring antibodies to fight the virus, reducing viral loads and protecting against lung damage.

SourcePurdue University·JournalProceedings of the National Academy of Sciences·DateNov 19, 2024

A single cell’s siesta

Researchers found that the cell's chloroplast shrinks by 40% in bright white light, minimizing damage. The structure responsible is a network of thin filaments that can contract and expand in all directions.

SourceUniversiteit van Amsterdam·JournalProceedings of the National Academy of Sciences·DateNov 18, 2024

First successful synthesis of naphthocyclinones since their discovery fifty years ago

Researchers at Institute of Science Tokyo develop an innovative strategy to produce β- and γ-naphthocyclinones, challenging compounds that have potential for medical and biological applications. They successfully synthesize the molecules using a retrosynthetic analysis approach, achieving yields of over 70%.

SourceInstitute of Science Tokyo·JournalAngewandte Chemie International Edition·TypeExperimental study·DateNov 18, 2024

CU Anschutz study shows association between climate change and eye maladies

A new study from the University of Colorado Anschutz Medical Campus found a significant association between climate change and ocular surface eye conditions, particularly when particulate matter from air pollution was prevalent. The researchers discovered that clinical visits for ocular surface irritation and conjunctivitis more than d...

SourceUniversity of Colorado Anschutz Medical Campus·JournalClinical Ophthalmology·TypeData/statistical analysis·DateNov 15, 2024

New study shows how salmonella tricks gut defenses to cause infection

A new UC Davis Health study has uncovered the mechanisms by which Salmonella bacteria evade the body's natural defenses in the gut. The research found that Salmonella alters the gut's nutrient environment to fuel its replication in the large intestine, creating an imbalance that helps the pathogen survive. This new understanding could ...

SourceUniversity of California - Davis Health·JournalProceedings of the National Academy of Sciences·DateNov 15, 2024

New route to ‘quantum spin liquid’ materials discovered for first time

Researchers at the University of Birmingham create a ruthenium-based material with complex disordered magnetic properties, fulfilling the Kitaev quantum spin liquid state requirements. This breakthrough opens up new pathways for exploring these states of matter and provides a route to magnetic properties that don't follow classical laws.

SourceUniversity of Birmingham·JournalNature Communications·TypeExperimental study·DateNov 15, 2024

FRIB research team identifies flaw in physics models of massive stars and supernovae

The FRIB research team has identified a flaw in physics models of massive stars and supernovae, revealing inconsistencies with observational gamma-ray astronomy data. This discovery was made possible by the development of a new experimental method that enabled the team to study short-lived isotopes, including iron-60.

New species discovered with refined DNA technology

Scientists at the University of Gothenburg have discovered four new species of daisies in South Africa using advanced DNA sequencing techniques. The discovery highlights the importance of integrating traditional observations with modern genetic analysis to better understand plant relationships and biodiversity.

SourceUniversity of Gothenburg·JournalSouth African Journal of Botany·TypeExperimental study·DateNov 13, 2024

McMaster University researchers uncover potential treatment for rare genetic disorders

Researchers at McMaster University have identified a potential treatment for Sandhoff and Tay-Sachs diseases, two rare lysosomal storage disorders that cause progressive damage to nerve cells. The FDA-approved drug 4-phenylbutyric acid (4-PBA) showed significant improvements in motor function, lifespan, and healthy motor neurons.

SourceMcMaster University·JournalHuman Molecular Genetics·TypeExperimental study·DateNov 13, 2024